Health Canada
- Status: approved
Aspirin with P2Y12 receptor inhibitor (Aspirin with P2Y12 receptor inhibitor) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Dong-A University is the originator. The local marketing authorisation holder may differ — check the official source linked above.